Is SKYE or TRAW more profitable?

TRAW runs the higher net margin — SKYE at 0.00% versus TRAW at 328.67%.

How have SKYE and TRAW total returns compared?

Over the past 10 years, SKYE delivered -46.85% and TRAW delivered -64.35% annualized total return. Past performance doesn't predict future results.

Skye Bioscience, Inc. (SKYE) vs Traws Pharma, Inc. (TRAW)

A side-by-side comparison of Skye Bioscience, Inc. and Traws Pharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

SKYE

Skye Bioscience, Inc.

$7M

$1.62HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

TRAW

Traws Pharma, Inc.

$8M

$0.52HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — SKYE vs TRAW

growth of $100 · dividends reinvested · last 10y

SKYE -99.8% (-47.3%/yr)TRAW -100.0% (-64.2%/yr)SKYE compounded faster over this window

Log scale — wide-divergence pair

SKYE TRAW

SKYE vs TRAW: by the numbers

•TRAW is the larger company ($8M vs $7M market cap).
•TRAW is profitable (328.67% net margin) while SKYE runs a net loss (0.00%).

Metrics side by side

Profitability

Metric	SKYE	TRAW
Gross margin	0.00%	100.00%
Operating margin	0.00%	-640.68%
Net margin	0.00%	328.67%

Growth (annualized)

Metric	SKYE	TRAW
Revenue CAGR (5Y)	N/A	64.60%
Total return CAGR (5Y)	-60.42%	-64.14%

Frequently asked

Is SKYE or TRAW more profitable?: TRAW runs the higher net margin — SKYE at 0.00% versus TRAW at 328.67%.
How have SKYE and TRAW total returns compared?: Over the past 10 years, SKYE delivered -46.85% and TRAW delivered -64.35% annualized total return. Past performance doesn't predict future results.

Go deeper

Full SKYE analysis Full TRAW analysis Interactive comparison tool

Dig into the metrics

Skye Bioscience ROE Traws Pharma ROE Skye Bioscience operating margin Traws Pharma operating margin Skye Bioscience revenue growth Traws Pharma revenue growth Skye Bioscience free cash flow Traws Pharma free cash flow

Skye Bioscience & Traws Pharma appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.